AFX-22202-14819
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 941 / CA
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-28
Dose 1 — Pfizer-BioNTech
-
2021-03-21
Dose 2 — Pfizer-BioNTech
-
2021-03-22
Registered in v-safe
- 2021-03-23
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Good · Site: PainFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-04-11
- 2021-04-18
- 2021-04-25
- 2021-05-02
- 2021-06-20
- 2021-09-19
-
2021-11-16
Dose 3 — Pfizer-BioNTech
-
2021-11-19
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-30
-
2021-12-07
Survey response — day 21, dose 3MedDRA: Tachycardia — Feeling: Good · Be unable to do your normal daily activitiesFree text: TachycardiaMedDRA releases: 2024-11 · check-in free text available
- 2021-12-14
- 2021-12-21
-
2021-12-30
Survey response — day 42, dose 3MedDRA: Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: TachycardiaMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Report sent to call center — day 42, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-05
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-02-15
- 2022-05-17
- 2022-11-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | |
| 2 | 2021-03-21 | Pfizer-BioNTech | |
| 3 | 2021-11-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Release 10 — day 21, dose 3
Symptoms: Tachycardia
Release 10 — day 42, dose 3
Symptoms: Tachycardia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Tachycardia | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release